Virpax Pharmaceuticals (VRPX): Price to Sales

Corporate company logo of Virpax Pharmaceuticals (VRPX)

Virpax Pharmaceuticals (VRPX) is developing innovative non-opioid drugs for the CNS and pain management utilizing mucosal delivery methods. This P/S chart reflects the dynamics of these R&D processes. While proprietary drug transport systems in hospitals allow for higher service pricing, the metric determines this level against a backdrop of liquidity shortage risks and the absence of stable cash flow.

Virpax - VRPX P/S Multiple (period 07/04/2022 - 11/15/2026)

Metric breakdowns and analytics for virpaxpharma.com (VRPX)

- share price and consensus valuation forecast:
Price Performance Chart Virpax Pharmaceuticals Inc.|VRPX - Price Target Chart
- stock exchange capitalization data:
Market Value Virpax Pharmaceuticals, Inc.|VRPX - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Net Assets per Single Share Virpax Pharmaceuticals|VRPX - Book Capitalization|Market Capitalization to Book Value virpaxpharma.com|VRPX - Aggregate Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Virpax Pharmaceuticals|VRPX - Long-Term Debt to Equity|Current Liabilities to Equity Virpax Pharmaceuticals, Inc.|VRPX - Company Aggregate Debts|Debts to Book Capitalization Virpax Pharmaceuticals, Inc.|VRPX - Company Long-Term Liabilities|Company Short-Term Indebtedness Virpax Pharmaceuticals|Intermediate Coverage Ratio virpaxpharma.com
- financial results and valuation multiples details:
VRPX - Company Net Income|Forward Earnings Virpax Pharmaceuticals|VRPX - P/E Multiple|Future Price to Earnings Multiple Virpax Pharmaceuticals, Inc.|VRPX - PEG Multiple|EV/EBITDA Multiple Virpax Pharmaceuticals|VRPX - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Virpax Pharmaceuticals|VRPX - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months virpaxpharma.com|VRPX - Earnings growth in current year|Earnings growth forecast for next year Virpax Pharmaceuticals
- issuer revenue and sales details:
VRPX - Revenue and Sales Volume|Company Future Sales Volume Virpax Pharmaceuticals, Inc.|VRPX - P/S Multiple|Market Cap to Future Revenue Ratio Virpax Pharmaceuticals, Inc.|VRPX - Revenue Growth YoY (Last 12 Months)
General company analysis:VRPX virpaxpharma.com
Finished products of Virpax Pharmaceuticals

To protect capital from market volatility, it is crucial for an investor to determine whether a company is overvalued relative to its actual earnings. Virpax Pharmaceuticals (VRPX) development of innovative drug delivery systems for the CNS provides fundamental stability, which is reflected in the price/sales ratio, measuring the market value of the business per unit of revenue to assess the efficiency of intellectual property monetization and minimize the risk of overpayment during portfolio construction.

Who Virpax Pharmaceuticals competes with

ALKS (Alkermes PLC) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio avadel.com AVDL|atai Life Sciences Corp (ATAI) - Price to Sales|GH Research Group - P/S Multiple|Mind Medicine (MNMD) - Market Cap to Revenue|COMPASS Corp (CMPS) - Price-to-Revenue Ratio|LBRX (LB Pharma) - Price-to-Revenue Ratio|DRUG (Bright Minds Corp) - P/S Multiple|Market Cap to Revenue Ratio VNDA (Vanda Pharmaceuticals Inc)|P/S Multiple CYBN|ANRO - Price to Sales|Price-to-Revenue Ratio NRx Pharmaceuticals NRXP|P/S Multiple Cingulate Inc. CING|SILO - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio CPHI (China Pharma Holdings, Inc.)|CMND: P/S Multiple|Psyence Biomedical Ltd. - Market Capitalization-to-Revenue Ratio|SPRC (SciSparc Ltd.) - P/S Multiple|SEEL (Seelos Therapeutics, Inc.) - Market Cap to Sales Volume|P/S Multiple KRTX